NASDAQ:CBIO
Delisted
Catalyst Biosciences Stock News
$0.511
+0 (+0%)
At Close: Dec 14, 2023
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Molecular Templates
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
09:05pm, Tuesday, 18'th Feb 2020
Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company developing novel treatments for hemophilia and other rare bleeding disorders, (the Company), today announced the closing o
NTAP, AEG among premarket losers
02:17pm, Thursday, 13'th Feb 2020
XBiotech (NASDAQ:XBIT) -26% on preliminary results of tender offer.Akorn (NASDAQ:AKRX) -20% after extending standstill period.Catalyst Biosciences (NASDAQ:CBIO) -18% on equity offering.Nu Skin En
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
02:15pm, Thursday, 13'th Feb 2020
Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company developing novel treatments for hemophilia and other rare bleeding disorders, (the Company), today announced the pricing
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
01:05pm, Thursday, 13'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (N
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
09:15pm, Wednesday, 12'th Feb 2020
Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company developing novel treatments for hemophilia and other rare bleeding disorders (the Company), today announced that it is off
16 Healthcare Stocks Moving In Friday's Pre-Market Session
12:39pm, Friday, 07'th Feb 2020
Gainers
• Assertio Therapeutics, Inc. (NASDAQ:ASRT) stock increased by 57.7% to $1.64 during Friday's pre-market session.
• Seelos Therapeutics, Inc. (NASDAQ:SEEL)...
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
Catalyst Biosciences, Inc. (CBIO), today announced positive efficacy and safety data from its Phase 2b trial of DalcA, a next-generation subcutaneously (SQ) administered Factor IX (FIX) therapy being
Edited Transcript of BDX earnings conference call or presentation 6-Feb-20 1:00pm GMT
02:58am, Friday, 07'th Feb 2020
Q1 2020 Becton Dickinson and Co Earnings Call
Becton, Dickinson (BDX) Q1 Earnings Beat, Revenues Rise Y/Y
02:24pm, Thursday, 06'th Feb 2020
Becton, Dickinson (BDX) sees softness in BD Medical unit, slashes FY20 view.
The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus
06:04pm, Sunday, 02'nd Feb 2020
Biotech stocks see-sawed through the week ended Jan. 31 and ended the month lower overall. Big pharma earnings of the week were mostly disappointing. Pfizer Inc. (NYSE: PFE ) reported disappointing fo
RegenXBio (RGNX) Receives a Rating Update from a Top Analyst
04:20pm, Wednesday, 29'th Jan 2020
In a report released today, Gbola Amusa from Chardan Capital reiterated a Buy rating on RegenXBio (RGNX), with a price target of $150.00. The company's
RegenXBio (RGNX) Receives a Rating Update from a Top Analyst
04:20pm, Wednesday, 29'th Jan 2020
In a report released today, Gbola Amusa from Chardan Capital reiterated a Buy rating on RegenXBio (RGNX – Research Report),
Chardan Capital Sticks to Their Buy Rating for uniQure (QURE)
06:50am, Wednesday, 29'th Jan 2020
Chardan Capital analyst Gbola Amusa reiterated a Buy rating on uniQure (QURE) today and set a price target of $125.00. The company's shares closed last
